Pneumoconiosis Damages Lawsuit
First written in FY2017-Q1. 8 of 22 entries say "Materialised", first in FY2020-Q3. Latest entry: FY2026.
Sumiseki Holdings moved to the "Worse" side of this theme in 2020.
0 other companies' latest entry also says "Materialised".
- FY2026MaterialisedAnnual report
「In addition, 3 former employees and others of coal mines and other operations managed by 住友石炭鉱業株式会社 in Hokkaido (now the Company's subsidiary 住石マテリアルズ株式会社, hereinafter "住石マテリアルズ") had sought damages from 住石マテリアルズ for pneumoconiosis, but the matter was concluded after payment of a ¥11 million settlement, recorded as an extraordinary loss.」
The newly filed pneumoconiosis damages claim by 3 people was concluded after payment of a ¥11 million settlement. - FY2025MaterialisedAnnual report
「In addition, 4 former employees and others of coal mines and other operations managed by 住友石炭鉱業株式会社 in Hokkaido (now the Company's subsidiary 住石マテリアルズ株式会社, hereinafter "住石マテリアルズ") had sought damages from 住石マテリアルズ for pneumoconiosis, but the matter was concluded after payment of a ¥29 million settlement, recorded as an extraordinary loss.」
The pneumoconiosis damages claim was concluded after payment of a ¥29 million settlement to 4 people. - FY2024-Q3MaterialisedAnnual report
「Settlement payment - 2」
A ¥2 million settlement payment was recorded as an extraordinary loss in the quarterly consolidated income statement. The filing does not provide details of the settlement matter concerned. - FY2023MaterialisedAnnual report
「In addition, 4 former employees and others of coal mines and other operations managed by 住友石炭鉱業株式会社 in Hokkaido (now the Company's subsidiary 住石マテリアルズ株式会社, hereinafter "住石マテリアルズ") had sought damages from 住石マテリアルズ for pneumoconiosis, but the matter was concluded after payment of a ¥15 million settlement, recorded as an extraordinary loss.」
The newly filed pneumoconiosis damages claim by 4 people was concluded after payment of a ¥15 million settlement. - FY2022MitigatedAnnual report
「In addition, 15 former employees and others of coal mines and other operations managed by 住友石炭鉱業株式会社 in Hokkaido (now the Company's subsidiary 住石マテリアルズ株式会社, hereinafter "住石マテリアルズ") had sought damages from 住石マテリアルズ for pneumoconiosis, but the matter was concluded after payment of a ¥67 million settlement, recorded as an extraordinary loss.」
The claim for pneumoconiosis damages by 15 people, which had been disclosed since the previous fiscal year, was concluded after payment of a ¥67 million settlement. - FY2022-Q3RestatedAnnual report
「In Hokkaido, 15 former employees or others formerly associated with coal mines and other operations managed by 住友石炭鉱業株式会社 (now the company’s subsidiary 住石マテリアルズ株式会社, hereinafter “住石マテリアルズ”) sought total damages of ¥74 million from 住石マテリアルズ for pneumoconiosis, and the company is currently examining the details.」
The company continues to examine the details of the ¥74 million pneumoconiosis damages claim filed by 15 former employees or others, which was disclosed in the previous quarter. - FY2022-Q2MaterialisedAnnual report
「In Hokkaido, 15 former employees or others formerly associated with coal mines and other operations managed by 住友石炭鉱業株式会社 (now the company’s subsidiary 住石マテリアルズ株式会社, hereinafter “住石マテリアルズ”) sought total damages of ¥74 million from 住石マテリアルズ for pneumoconiosis, and the company is currently examining the details.」
The company has disclosed that it received new pneumoconiosis damages claims totaling ¥74 million from 15 former employees or others and is examining the details. - FY2020RestatedAnnual report
「Settlement proceeds ¥47 million」
The full-year results also indicate that ¥47 million in settlement proceeds was recorded in connection with the new pneumoconiosis damages claims in Hokkaido. - FY2020-Q3MaterialisedAnnual report
「In April 2019, 9 pneumoconiosis patients who were former employees or others formerly associated with coal mines and other operations managed in Hokkaido by 住友石炭鉱業株式会社 (now the company’s subsidiary 住石マテリアルズ株式会社, hereinafter “住石マテリアルズ”) sought damages for pneumoconiosis from 住石マテリアルズ outside court proceedings. 住石マテリアルズ investigated the facts and held discussions with the representatives of the former employees and others. In January 2020, the parties agreed to resolve the matter by settlement, and 住石マテリアルズ agreed to pay total settlement proceeds of ¥47 million to the 9 pneumoconiosis patients.」
The company received new out-of-court damages claims from 9 pneumoconiosis patients and agreed in January 2020 to pay total settlement proceeds of ¥47 million. The ¥47 million settlement payment was recorded as an extraordinary loss. - FY2019RestatedAnnual report
「The recording of ¥300 million in litigation-related losses as an extraordinary loss」
The company recorded ¥300 million in litigation-related losses in connection with the settlement of the pneumoconiosis damages litigation, and the provision for litigation losses had no balance at period-end. - FY2019-Q3MitigatedAnnual report
「The recording of ¥300 million in litigation-related losses as an extraordinary loss」
For the settled pneumoconiosis litigation, ¥300 million in litigation-related losses was recorded as an extraordinary loss. The provision for litigation losses on the balance sheet declined from ¥700 million to nil. - FY2019-Q2MitigatedAnnual report
「A settlement was reached on 20 September 2018 with the plaintiffs’ group in the damages litigation concerning pneumoconiosis, ¥1,000 million was paid on 28 September 2018, and the difference of ¥300 million from the ¥700 million provision for litigation losses was recorded as an extraordinary loss.」
A settlement was reached with the plaintiffs’ group in the pneumoconiosis damages litigation, and ¥1,000 million was paid. The difference of ¥300 million from the ¥700 million provision for litigation losses was recorded as a litigation-related loss, completing the immediate payments related to the litigation. - FY2019-Q1RestatedAnnual report
「Litigation was subsequently initiated in 6 rounds, bringing the number of plaintiffs to 128 patients and the total damages claimed to ¥1,839 million.」
The company has restated the status of the pneumoconiosis damages litigation: 6 rounds of filings, 128 plaintiffs, and total claims of ¥1,839 million. - FY2018WorsenedAnnual report
「Litigation was subsequently initiated in 6 rounds, bringing the number of plaintiffs to 128 patients and the total damages claimed to ¥1,839 million.」
The litigation status is unchanged from the previous period, with 128 plaintiffs and total claims of ¥1,839 million. However, the provision for litigation losses increased from ¥400 million at the end of the previous fiscal year to ¥700 million, with ¥300 million recorded during the current fiscal year. - FY2018-Q3RestatedAnnual report
「Litigation was subsequently initiated in 6 rounds, bringing the number of plaintiffs to 128 patients and the total damages claimed to ¥1,839 million.」
The company has restated the status of the pneumoconiosis damages litigation: 6 rounds of filings, 128 plaintiffs, and total claims of ¥1,839 million. - FY2018-Q1WorsenedAnnual report
「Litigation was subsequently initiated in 6 rounds, bringing the number of plaintiffs to 128 patients and the total damages claimed to ¥18.39 million.」
The litigation advanced from the fifth to the sixth round of filings, and the number of plaintiffs increased from 117 to 128. Total claims are stated as ¥18.39 million, as indicated in the text. - FY2017WorsenedAnnual report
「Litigation was subsequently initiated in 5 rounds, bringing the number of plaintiffs to 117 patients and the total damages claimed to ¥1,703 million.」
The pneumoconiosis litigation advanced from the third to the fifth round of filings, the number of plaintiffs increased from 113 to 117, and total claims increased from ¥1,651 million to ¥1,703 million. - FY2017-Q3RestatedAnnual report
「Litigation was subsequently initiated in 3 rounds, bringing the number of plaintiffs to 113 patients and the total damages claimed to ¥1,651 million.」
The company has restated the status of the pneumoconiosis damages litigation: 113 plaintiffs and total claims of ¥1,651 million. - FY2017-Q2RestatedAnnual report
「Litigation was subsequently initiated in 3 rounds, bringing the number of plaintiffs to 113 patients and the total damages claimed to ¥1,651 million.」
The company has restated the status of the pneumoconiosis damages litigation: 113 plaintiffs and total claims of ¥1,651 million. - FY2017-Q1First statedAnnual report
「The company, its subsidiary 住石マテリアルズ株式会社 (hereinafter, “住石マテリアルズ”), and 住石貿易株式会社 were sued for damages in December 2014 by patients claiming to suffer from pneumoconiosis. Litigation was subsequently initiated in 3 rounds, bringing the number of plaintiffs to 113 patients and the total damages claimed to ¥1,651 million.」
Litigation concerning pneumoconiosis was actually filed, involving 113 plaintiffs and total claims of ¥1,651 million. The company stated that it would examine the plaintiffs’ assertions through the litigation and present its own arguments.